Özer Şehirli, A. Et Al. 2021. The effects of spironolactone in preventing bile duct ligation-induced hepatitis in a rat model. Iranian Journal of Pharmaceutical Research , vol.20, no.2 , 35-44.

Özer Şehirli, A., Kökeş, A., VELİOĞLU ÖĞÜNÇ, A., TETİK, Ş., Özkan, N., ÇETİNEL, Ş., ... Sayıner, S.(2021). The effects of spironolactone in preventing bile duct ligation-induced hepatitis in a rat model. Iranian Journal of Pharmaceutical Research , vol.20, no.2, 35-44.

Özer Şehirli, Ahmet Et Al. "The effects of spironolactone in preventing bile duct ligation-induced hepatitis in a rat model," Iranian Journal of Pharmaceutical Research , vol.20, no.2, 35-44, 2021

Özer Şehirli, Ahmet Ö. Et Al. "The effects of spironolactone in preventing bile duct ligation-induced hepatitis in a rat model." Iranian Journal of Pharmaceutical Research , vol.20, no.2, pp.35-44, 2021

Özer Şehirli, A. Et Al. (2021) . "The effects of spironolactone in preventing bile duct ligation-induced hepatitis in a rat model." Iranian Journal of Pharmaceutical Research , vol.20, no.2, pp.35-44.

@article{article, author={Ahmet Özer Şehirli Et Al. }, title={The effects of spironolactone in preventing bile duct ligation-induced hepatitis in a rat model}, journal={Iranian Journal of Pharmaceutical Research}, year=2021, pages={35-44} }